Talley NJ et al. |
Eradication of Helicobacter pylori in functional dyspepsia: randomised double blind placebo controlled trial with 12 months' follow up. The Optimal Regimen Cures Helicobacter Induced Dyspepsia (ORCHID) Study Group. |
1999 |
BMJ |
pmid:10092259
|
Khoo KH et al. |
Altered expression profile of the surface glycopeptidolipids in drug-resistant clinical isolates of Mycobacterium avium complex. |
1999 |
J. Biol. Chem. |
pmid:10092667
|
Torgano G et al. |
Treatment of Helicobacter pylori and Chlamydia pneumoniae infections decreases fibrinogen plasma level in patients with ischemic heart disease. |
1999 |
Circulation |
pmid:10096930
|
Navuluri R and Yue S |
Understanding peptic ulcer disease pharmacotherapeutics. |
1999 |
Nurse Pract |
pmid:10100245
|
Tirén U et al. |
Helicobacter pylori gastritis in children: efficacy of 2 weeks of treatment with clarithromycin, amoxicillin and omeprazole. |
1999 |
Acta Paediatr. |
pmid:10102149
|
Graham DY et al. |
Ranitidine bismuth citrate, tetracycline, clarithromycin twice-a-day triple therapy for clarithromycin susceptible Helicobacter pylori infection. |
1999 |
Aliment. Pharmacol. Ther. |
pmid:10102946
|
Zanten SJ et al. |
The DU-MACH study: eradication of Helicobacter pylori and ulcer healing in patients with acute duodenal ulcer using omeprazole based triple therapy. |
1999 |
Aliment. Pharmacol. Ther. |
pmid:10102960
|
Van der Wouden EJ et al. |
The influence of metronidazole resistance on the efficacy of ranitidine bismuth citrate triple therapy regimens for Helicobacter pylori infection. |
1999 |
Aliment. Pharmacol. Ther. |
pmid:10102961
|
Wong BC et al. |
Triple therapy for Helicobacter pylori eradication is more effective than long-term maintenance antisecretory treatment in the prevention of recurrence of duodenal ulcer: a prospective long-term follow-up study. |
1999 |
Aliment. Pharmacol. Ther. |
pmid:10102962
|
Xiao SD et al. |
High cure rate of Helicobacter pylori infection using tripotassium dicitrato bismuthate, furazolidone and clarithromycin triple therapy for 1 week. |
1999 |
Aliment. Pharmacol. Ther. |
pmid:10102963
|
Liu WZ et al. |
Furazolidone-containing short-term triple therapies are effective in the treatment of Helicobacter pylori infection. |
1999 |
Aliment. Pharmacol. Ther. |
pmid:10102964
|
Huang J and Hunt RH |
Clarithromycin-based triple therapies. |
1999 |
Aliment. Pharmacol. Ther. |
pmid:10102978
|
Kohyama T et al. |
Fourteen-member macrolides inhibit interleukin-8 release by human eosinophils from atopic donors. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10103198
|
Dempsey CL et al. |
Drug usage evaluation: clarithromycin as sequential therapy. |
1993 |
Hosp Formul |
pmid:10130382
|
Craig AM et al. |
Decision analysis of Helicobacter pylori eradication therapy using omeprazole with either clarithromycin or amoxicillin. |
1996 |
Pharmacoeconomics |
pmid:10160472
|
Gimenez Garcia R et al. |
Fish tank granuloma: response to treatment with clarithromycin. |
1999 |
J Eur Acad Dermatol Venereol |
pmid:10188167
|
Fournier S et al. |
Effect of adding clofazimine to combined clarithromycin-ethambutol therapy for Mycobacterium avium complex septicemia in AIDS patients. |
1999 |
Eur. J. Clin. Microbiol. Infect. Dis. |
pmid:10192709
|
Gómez-Gil E et al. |
Clarithromycin-induced acute psychoses in peptic ulcer disease. |
1999 |
Eur. J. Clin. Microbiol. Infect. Dis. |
pmid:10192720
|
Rosário M et al. |
[Profile of the resistance to macrolides and imidazoles of Helicobacter pylori in a sample of the Portuguese population]. |
1998 |
Acta Med Port |
pmid:10192979
|
Lee CK et al. |
Immunization with recombinant Helicobacter pylori urease decreases colonization levels following experimental infection of rhesus monkeys. |
1999 |
Vaccine |
pmid:10195786
|